Yong Yean Chau, CEO of Parkway Life REIT's manager. (Parkway Life REIT)

Parkway Life REIT (PLife REIT) has given an indication of where it will be pursuing acquisition opportunities in the coming years.

These indications were given in response to questions from REITsWeek at a media briefing on 14 July, during which the REIT also elaborated on the terms of the new master lease agreements (MLAs( it has put forward for its Singapore hospitals.

As part of terms for the new MLAs, PLife REIT will also be granted with a right-of-first-refusal (ROFR) on Mount Elizabeth Novena - an acquisition that is expected to cost the REIT more than SGD1.2 billion should it materialise.

Related: PLife REIT to receive ROFR for Mount Elizabeth Novena as part of new lease agreements

Dear members, please login to continue reading this article.

Don’t miss out on information beyond mainstream media reports that may impact your investments.
Login or sign-up for a free 25-day trial here. Why subscribe?

By Ridzwan Rahmat

Ridzwan has been analysing REITs and business trusts since 2008, and personally manages a portfolio comprising mainly of SGX-listed REITs. He founded REITsWeek in 2013.